These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7880107)

  • 1. [Development of drugs to overcome drug resistance--basic approaches].
    Tsuruo T
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):365-70. PubMed ID: 7880107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Overcoming of multidrug resistance and its clinical application].
    Tsuruo T
    Nihon Rinsho; 1997 May; 55(5):1111-5. PubMed ID: 9155161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of multidrug resistance by a novel quinoline derivative, MS-209.
    Sato W; Fukazawa N; Nakanishi O; Baba M; Suzuki T; Yano O; Naito M; Tsuruo T
    Cancer Chemother Pharmacol; 1995; 35(4):271-7. PubMed ID: 7828268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16, and their synergistic modulation of multidrug resistance].
    Naito M; Tsuruo T
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):395-402. PubMed ID: 7906507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro.
    Vilpo J; Koski T; Vilpo L
    Haematologica; 2000 Aug; 85(8):806-13. PubMed ID: 10942926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MDR reversing drugs for clinical development].
    Tsuruo T
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):962-7. PubMed ID: 8002634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoring uptake and retention of daunorubicin and idarubicin in P170-related multidrug resistance cells by low concentration D-verapamil, cyclosporin-A and SDZ PSC 833.
    Michieli M; Damiani D; Michelutti A; Candoni A; Masolini P; Scaggiante B; Quadrifoglio F; Baccarani M
    Haematologica; 1994; 79(6):500-7. PubMed ID: 7896208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of four drug-resistant P388 sublines: resistance/sensitivity in vivo, resistance-and proliferation-markers, immunogenicity.
    Fichtner I; Stein U; Hoffmann J; Winterfeld G; Pfeil D; Hentschel M
    Anticancer Res; 1994; 14(5A):1995-2003. PubMed ID: 7847840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
    Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P
    Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired vs innate multidrug resistance and the effect of calcium channel blockers.
    Tsuruo T
    Prog Clin Biol Res; 1986; 223():203-16. PubMed ID: 3468516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-(3,4-dimethyoxyphenyl)-3,4-dihydro-6,7-dimethoxy-alpha- [(4-methylphenyl)thio]-2(1H)-isoquinolineheptanenitrile (CL 329,753): a novel chemosensitizing agent for P-glycoprotein-mediated resistance with improved biological properties compared with verapamil and cyclosporine A.
    Greenberger LM; Collins KI; Annable T; Boni JP; May MK; Lai FM; Kramer R; Citeralla RV; Hallett WA; Powell D
    Oncol Res; 1996; 8(5):207-18. PubMed ID: 8884813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of multidrug resistance by tacrolimus hydrate.
    Wu J; Furusawa S; Nakano S; Takahashi M; Chiba H; Takayanagi M; Takayanagi Y; Sasaki K
    Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):651-8. PubMed ID: 9121220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
    Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
    Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo models of P-glycoprotein-mediated multidrug resistance.
    Gottesman MM; Mickisch GH; Pastan I
    Cancer Treat Res; 1994; 73():107-28. PubMed ID: 7710902
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct interaction between verapamil and doxorubicin causes the lack of reversal effect of verapamil on P-glycoprotein mediated resistance to doxorubicin in vitro using L1210/VCR cells.
    Breier A; Drobná Z; Barancík M
    Neoplasma; 1998; 45(4):248-53. PubMed ID: 9890669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RS-33295-198: a novel, potent modulator of P-glycoprotein-mediated multidrug resistance.
    Slate DL; Bruno NA; Casey SM; Zutshi N; Garvin LJ; Wu H; Pfister JR
    Anticancer Res; 1995; 15(3):811-4. PubMed ID: 7645963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe combined immunodeficiency (SCID) mouse modeling of P-glycoprotein chemosensitization in multidrug-resistant human myeloma xenografts.
    Bellamy WT; Odeleye A; Huizenga E; Dalton WS; Weinstein RS; Grogan TM
    Clin Cancer Res; 1995 Dec; 1(12):1563-70. PubMed ID: 9815957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circumvention of multidrug resistance by a newly synthesized quinoline derivative, MS-073.
    Sato W; Fukazawa N; Suzuki T; Yusa K; Tsuruo T
    Cancer Res; 1991 May; 51(9):2420-4. PubMed ID: 1673087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MDR (Multiple Drug Resistant) type of resistance to chemotherapy in clinical practice].
    Oudard S; Marie JP; Pujade Lauraine E
    Bull Cancer; 1996 Aug; 83(8):609-18. PubMed ID: 8869040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of S9788, cyclosporin A and verapamil on intracellular distribution of THP-doxorubicin in multidrug-resistant K562 tumor cells, as studied by laser confocal microspectrofluorometry.
    Sebille S; Morjani H; Poullain MG; Manfait M
    Anticancer Res; 1994; 14(6A):2389-93. PubMed ID: 7825978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.